Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate

NCT06427785 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT06427785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06427785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate
Lead sponsor
Beijing Chao Yang Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2024
Completion date
August 15, 2025
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia awareness, remimazolam, sedative, hypnotic, or anxiolytic withdrawal